Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants

Conditions: Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue

Sex: All

Ages: N/A – 12 Weeks

Phase: NA

Enrollment: 30

Sponsor: Hospital Clinic of Barcelona

Summary

This study has been designed to demonstrate that red blood cell from umbilical cord blood (UCB-RBC) is a safe and available product for extremely preterm infants (EPI) transfusion and that transfusion of UCB-RBC is non-less effective than RBC from adult donor for the treatment of anemia of prematurity in this group of patients.

Eligibility Criteria

Inclusion Criteria:Signed informed consent from parents or legal guardiansPreterm infants born earlier than 28 weeks of gestational age.Admission to the neonatal intensive care unit of the participating hospital (Hospital Clínic of Barcelona)Exclusion Criteria:Previous transfusionIsoimmunizationHydrops fetalisMajor congenital malformationsCongenital infectionsHemoglobinopathiesExtreme urgency of blood availability (hypovolemic shock, disseminated intravascular coagulopathy...)Be part of another clinical trial that may interfere with the results

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05612919). StuddyBuddy aggregates publicly available trial information.